New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareMK-677 (Ibutamoren) vs GHK

MK-677 (Ibutamoren) vs GHK

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone Peptides
MK-677 (Ibutamoren)
Skin & CosmeticAnti-Aging & Longevity
GHK
Summary
MK-677 (Ibutamoren) is an orally active, non-peptide ghrelin receptor agonist that increases growth hormone and IGF-1 levels. Unlike injectable GHRPs, it can be taken orally and has a 24-hour half-life, making it convenient for sustained GH optimization.
GHK is the natural tripeptide (Gly-His-Lys) released from human albumin that activates tissue remodeling, collagen synthesis, and anti-aging gene expression. The copper-free form is the biological signaling molecule; it chelates copper in tissue to form GHK-Cu but also has independent biological activity.
Half-Life
24 hours
Extremely short as free peptide; tissue binding extends local effects
Admin Route
Oral
SubQ, Topical, Oral
Research
Typical Dose
10–25 mg
100–500 mcg
Frequency
Once daily
Daily or 5x per week
Key Benefits
  • Increases lean muscle mass
  • Enhances bone density
  • Improves sleep quality and REM sleep
  • Accelerates recovery from training
  • Increases appetite
  • May improve skin elasticity and appearance
  • Supports fat loss while maintaining muscle
  • Oral administration — no injections required
  • 24-hour half-life allows once-daily dosing
  • Stimulates collagen and extracellular matrix synthesis
  • Activates tissue repair gene expression programs
  • Anti-aging: reverses 57% of age-related gene changes
  • Antioxidant and anti-inflammatory
  • Wound healing and skin barrier repair
  • Improves skin laxity, texture, and radiance
  • Neuroprotective (stimulates NGF, BDNF)
  • Anti-fibrotic in liver and lung models
Side Effects
  • Increased appetite (significant in some users)
  • Water retention and puffiness
  • Elevated blood glucose / insulin resistance (monitor in diabetics)
  • Lethargy initially
  • +2 more
  • Excellent safety profile (naturally occurring peptide)
  • Rare: mild injection site reaction (SC)
  • No significant adverse effects identified in research
Stacks With